Soleus Capital
Finance · Connecticut, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
104 Field Point Rd Ste 200, Greenwich, C...Phone Number
(475) 208-3178Website
www.soleuscapital.comRevenue
<$5 MillionIndustry
ZI Rank: 2
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
3
3
2
2
About Soleus Capital
Soleus Capital is a healthcare investment firm that specializes in innovative life sciences sectors, including biotech, medtech, diagnostics, and genomics. The firm invests across the healthcare lifecycle, targeting both developmental-stage and commercial companies. Their focus is on advancing healthcare solutions through strategic investments in cutting-edge technologies. Soleus Capital aims to support the growth of companies that are shaping the future of healthcare.Explore more
Soleus Capital Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Soleus Capital your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Soleus Capital had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Soleus Capital recently announced quarterly report
Check out if Soleus Capital is spiking on competitors!
Funding: Get notified immidiatlly once Soleus Capital has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Soleus Capital has recently received funding, and reach out quickly before it becomes old news!
Soleus Capital, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Soleus Capital launches new products
Congratulate Masked Content for being promoted to Masked Content at Soleus Capital
Recommended Actions
Find VP level buyers at Soleus Capital
Find 2 more new buyers
Compare Similar Companies to Soleus Capital
Compare insights from companies similar to Soleus Capital, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Soleus Capital is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
Soleus Capital is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about Soleus Capital.
Soleus Capital Tech Stack
A closer look at the technologies used by Soleus Capital
See more technologies
Most Recent Scoops
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Soleus Capital News & Media
Soleus Capital Issues Letter to The Board of Theratechnologies
GREENWICH, Conn.--(BUSINESS WIRE)--Soleus Capital Management, L.P. (“Soleus Capital”), a healthcare investment firm which owns in excess of 10% of the stock of Theratechnologies Inc. (NASDAQ: THTX) (the “Company”), today sent a letter to the Board of Directors of the Company. In its letter, Soleus Capital described its belief that an acquisition of the Company is in the best interest of the Company’s shareholders and urged the Board to pursue an acquisition offer announced earlier todayStar Therapeutics Raises $90M in Series C Funding
Star Therapeutics, a South San Francisco, CA-based biotechnology company advancing antibody therapies, raised $90M in Series C funding. The round was led by Sofinnova Investments, and included new investors Qatar Investment Authority (QIA), Catalio Capital Management, Agent Capital, Soleus Capital, and NYBC Ventures, as well as participation from all existing investors including Westlake Village BioPartners, […] The post Star Therapeutics Raises $90M in Series C Funding appeared first on FinSMEsBeta Bionics Closes $57M Series C Financing
Beta Bionics, a Concord, MA-based clinical stage medical technology company, raised $57M in Series C funding. The round was led by Soleus Capital, Perceptive Advisors, Farallon Capital Management, L.L.C., RTW Investments, LP, and Eventide Asset Management with participation from Pura Vida Investments, ArrowMark Partners, LifeSci Venture Partners, and Novo Nordisk. This financing adds to the […] The post Beta Bionics Closes $57M Series C Financing appeared first on FinSMEs.
Read more news
Top Finance Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Soleus Capital
Sign Up For FreeTo access detailed company insights
Soleus Capital is a healthcare investment firm that specializes in innovative life sciences sectors, including biotech, medtech, diagnostics, and genomics. The firm invests across the healthcare lifecycle, targeting both developmental-stage and commercial companies. Their focus is on advancing healthcare solutions through strategic investments in c... Read More
